Flowstint
product
3 mentions
1 recordings
first heard Dec 2025
last heard 16 Dec
↑3 vs the 12 months before
Flowstint, a device treatment for benign prostatic hyperplasia, developed by Rivermark.
Trend
Peak in the week of 12 Dec — 3 mentions across 1 series.
Moments
newest first · ▶ plays the momentScott Nelson LiveThe Hidden Drivers of Clinical Trial Success: Interview with... · 8:48 · 16 Dec
…And what the flow stent is intended to be is a first line device option.…
Scott Nelson LiveThe Hidden Drivers of Clinical Trial Success: Interview with... · 1:29 · 16 Dec
…Flowstint works with equipment urologists use every day, turning diagnostic visits into therapeutic interventions without new capital, training, or scheduling complexity.…
Scott Nelson LiveThe Hidden Drivers of Clinical Trial Success: Interview with... · 0:55 · 16 Dec
…In this episode of MedCider, I sat down with Dr. Adam Kadlec, co-founder and CEO of Rivermark Medical, a urology-focused medtech company developing Flowstint, a first-line device treatment for benign prostatic hyperplasia, or BPH, as most of us know it.…
All 3 moments